Is ABIO.PA undervalued or overvalued?
As of 2025-03-17, the Intrinsic Value of Albioma SA (ABIO.PA) is 23.69 EUR. This ABIO.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 47.14 EUR, the upside of Albioma SA is -49.80%. This means that ABIO.PA is overvalued by 49.80%.
The range of the Intrinsic Value is 4.96 - 89.81 EUR
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 4.96 - 89.81 | 23.69 | -49.8% |
DCF (Growth 10y) | 17.30 - 125.82 | 41.40 | -12.2% |
DCF (EBITDA 5y) | 47.19 - 69.60 | 56.12 | 19.1% |
DCF (EBITDA 10y) | 54.00 - 89.01 | 68.26 | 44.8% |
Fair Value | 22.23 - 22.23 | 22.23 | -52.83% |
P/E | 22.20 - 41.59 | 29.63 | -37.2% |
EV/EBITDA | 29.83 - 49.49 | 38.74 | -17.8% |
EPV | 23.96 - 54.91 | 39.44 | -16.3% |
DDM - Stable | 18.74 - 56.84 | 37.79 | -19.8% |
DDM - Multi | 32.79 - 71.72 | 44.41 | -5.8% |
Market Cap (mil) | 1,528.28 |
Beta | 0.37 |
Outstanding shares (mil) | 32.42 |
Enterprise Value (mil) | 2,563.95 |
Market risk premium | 5.82% |
Cost of Equity | 6.67% |
Cost of Debt | 7.67% |
WACC | 6.19% |